Antibodies Against Various Forms of Mildly Oxidized Low-Density Lipoprotein Are Not Associated With Carotid Intima-Media Thickness in Patients With Primary Hyperlipidemia

Abstract

The carotid intima-media thickness (IMT) can reflect early atherosclerosis. Oxidative modification of low-density lipoprotein (LDL) leads to the formation of several immunogenic epitopes and different forms of antibodies against oxidized LDL (oxLDL). We investigated the possible relationship between autoantibody titers against various forms of mildly oxLDL and carotid IMT in patients (n=100) with primary hyperlipidemia. Three different types of mildly oxidized LDL—oxLDL_L, oxLDL_P, and oxLDL_D—were prepared at the end of lag, propagation, and decomposition phases of oxidation, respectively. Similar types of oxLDL were also prepared from the same LDL preparations after inactivation of the LDL-associated platelet-activating factor acetylhydrolase (PAF-AH). These types were denoted as oxLDL(-)_L, oxLDL(-)_P, and oxLDL(-)_D. OxLDL types are primarily enriched in lysophosphatidylcholine (lyso-PC) due to hydrolysis of oxidized phospholipids (oxPL) by PAF-AH. OxLDL(-) types are mainly enriched in intact oxPL due to the inactivation of the LDL-associated PAF-AH before oxidation. IgG autoantibodies against all types of oxLDL were determined and IMT was evaluated ultrasonographically. IMT values were significantly associated with age, systolic blood pressure and serum triglyceride levels, whereas no correlation was found between IMT values and antibody titers against all types of either oxLDL or oxLDL(-). We suggest that autoantibodies against various types of mildly oxidized LDL enriched either in lyso-PC or in oxPL are not associated with the extent of carotid atherosclerosis. This supports the concept that extensively oxidized LDL enriched in aldehydes rather than mildly oxidized LDL may play a prominent role in the early stage of atherosclerosis.

Get full access to this article

View all access options for this article.

References

Steinberg D , Parthasarathy S , Carew TE , et al : Beyond cholesterol: Modifications of low-density lipo-protein that increase its atherogenicity. N Engl J Med 320: 915-924, 1989.

Bhakdi S , Lackner KJ , Han S-R , et al : Beyond cholesterol: The enigma of atherosclerosis revisited. Thromb Haemost 91: 639-645, 2004.

Clare K , Hardwick SJ , Carpenter KL , et al : Toxicity of oxysterols to human monocyte-macrophages. Atherosclerosis 118: 67-75, 1995.

Kugiyama K , Kerns SA , Morrisett JD , et al : Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature 344: 160-162, 1990.

Fukumoto M , Shoji T , Emoto M , et al : Antibodies against oxidized LDL and carotid artery intima-media thickness in a healthy population. Arterioscler Thromb Vasc Biol 20: 703-707, 2000.

Salonen JT , Yla-Herttuala S , Yamamoto R , et al : Autoantibody against oxidized LDL and progression of carotid atherosclerosis. Lancet 339: 883-887, 1992.

Maggi E , Chiesa R , Melissano G , et al : LDL oxidation in patients with severe carotid atherosclerosis. A study of in vitro and in vivo oxidation markers. Arterioscler Thromb 14: 1892-1899, 1994.

Tselepis AD , Chapman MJ : Inflammation, bioactive lipids and atherosclerosis: Potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase. Atheroscler Suppl 3: 57-68, 2002.

Karasawa K , Harada A , Satoh N , et al : Plasma platelet activating factor-acetylhydrolase (PAF-AH). Prog Lipid Res 42: 93-114, 2003.

10.

Liapikos ThA , Antonopoulou S , Karabina S-AP , et al : Platelet-activating factor formation during oxidative modification of low-density lipoprotein when PAF-acetylhydrolase has been inactivated. Biochim Biophys Acta 1212: 353-360, 1994.

11.

Lourida E , Tsouli SG , Kiortsis DN , et al : The levels of autoantibodies against oxidised LDL in hypercholesterolemic patients are influenced by the LDL-associated PAF-acetylhydrolase activity. Atherosclerosis Suppl 5: 133-133, 2004.

12.

Cheng KS , Mikhailidis DP , Hamilton G , et al : A review of the carotid and femoral intima-media thickness as an indicator of the presence of peripheral vascular disease and cardiovascular risk factors. Cardiovasc Res 54: 528-538, 2002.

13.

Bots ML , Hoes AW , Koudstaal PJ , et al : Common carotid intima-media thickness and risk of stroke and myocardial infarction: The Rotterdam Study. Circulation 96: 1432-1437, 1997.

14.

Burke GL , Evans GW , Riley WA , et al : Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study. Stroke 26: 386-391, 1995.

15.

Hulthe J , Bokemark L , Fagerberg B : Antibodies to oxidised LDL in relation to intima-media-thickness in carotid and femoral arteries in 58-year-old subjectively clinically healthy men. Arterioscler Thromb Vasc Biol 21: 101-107, 2001.

16.

Liu ML , Ylitalo K , Salonen R , et al : Circulating oxidized low-density lipoprotein and its association with carotid intima-media thickness in asymptomatic members of familial combined hyperlipidemia families. Arterioscler Thromb Vasc Biol 24: 1492-1497, 2004.

17.

Hulthe J , Wiklund O , Hurt-Camejo E , et al : Antibodies to oxidized LDL in relation to carotid atherosclerosis, cell adhesion molecules, and phospholipase A(2). Arterioscler Thromb Vasc Biol 21: 269-274, 2001.

18.

Iribarren C , Folsom AR , Jacobs DR Jr , et al : Association of serum vitamin levels, LDL, susceptibility to oxidation, and autoantibodies against MDA-LDL with carotid atherosclerosis. Arterioscler Thromb Vasc Biol 17: 1171-1177, 1997.

19.

Frostegard J , Wu R , Lemne C , et al : Circulating oxidized low-density lipoprotein is increased in hyper-tension. Clin Sci (Lond) 105: 615-620, 2003.

20.

Wu R , de Faire U , Lemne C , et al : Autoantibodies to OxLDL are decreased in individuals with borderline hypertension. Hypertension 33: 53-59, 1999.

21.

Karvonen J , Paivansalo M , Kesaniemi YA , et al : Immunoglobulin M type of autoantibodies to oxidized low-density lipoprotein has an inverse relation to carotid artery atherosclerosis. Circulation 108: 2107-2112, 2003.

22.

Avogaro P , Bon GB , Cazzolato G : Presence of a modified low-density lipoprotein in humans. Arteriosclerosis 8: 79-87, 1988.

23.

Sevanian A , Bittolo-Bon G , Cazzolato G , et al : LDL is a lipid hydroperoxide-enriched circulating lipoprotein. J Lipid Res 38: 419-428, 1997.

24.

Edelstein C , Pfaffinger D , Hinman J , et al : Lysinephosphatidylcholine adducts in kringle V impart unique immunological and potential pro-inflamma-tory properties to human apolipoprotein(a). J Biol Chem 278: 52841-52847, 2003.

25.

Wu R , Huang YH , Elinder LS , et al : Lysophosphatidylcholine is involved in the antigenicity of oxidized LDL. Arterioscler Thromb Vasc Biol 18: 626-630, 1998.

26.

Dentan C , Tselepis AD , Chapman MJ , et al : Pefabloc, 4-[2-aminoethyl]benzenesulfonyl fluoride, is a new, potent nontoxic and irreversible inhibitor of PAF-de-grading acetylhydrolase. Biochim Biophys Acta 1299: 353-357, 1996.

27.

Karabina S-AP , Liapikos TA , Grekas G , et al : Distribution of PAF-acetylhydrolase activity in human plasma low-density lipoprotein. Biochim Biophys Acta 1213: 34-38, 1994.

28.

Craig WY , Raytcheva SE , Poulin SE , et al : Effect of low-density lipoprotein (LDL) antigen source on an enzyme-linked immunosorbent assay for autoanti-bodies against oxidized LDL. Ann Clin Biochem 36: 333-339, 1999.

29.

Craig WY , Rawstron MW , Rundell CA , et al : Relationship between lipoprotein- and oxidation-related variables and atheroma lipid composition in subjects undergoing coronary artery bypass graft surgery. Arterioscler Thromb Vasc Biol 19: 1512-1517, 1999.

30.

Kiortsis DN , Tsouli S , Lourida ES , et al : Lack of association between carotid intima-media thickness and PAF-acetylhydrolase mass and activity in patients with primary hyperlipidemia. Angiology 56: 451-458, 2005.

31.

Holvoet P , Perez G , Bernar H , et al : Stimulation with a monoclonal antibody (mAb4E4) of scavenger receptor-mediated uptake of chemically modified low-density lipoproteins by THP-1-derived macrophages enhances foam cell generation. J Clin Invest 93: 89-98, 1994.

32.

Ehara S , Ueda M , Naruko T , et al : Elevated levels of oxidized low-density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation 103: 1955-1960, 2001.